ZBTB35 and non-small cell lung carcinoma: Kaplan-Meier analysis further indicated that NSCLC patients with higher ZNF131 expression (52.953 ± 3.204) experienced shorter overall survival times compared to those with lower ZNF131 expression (69.837 ± 2.982, P = 0.053, Figure 2K).